Get the Stockscreener App
9.48
0.96%
0.09
Evolent Health Inc stock is traded at $9.48, with a volume of 2.02M.
It is up +0.96% in the last 24 hours and down -1.25% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$9.39
Open:
$9.39
24h Volume:
2.02M
Relative Volume:
0.84
Market Cap:
$1.11B
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-10.09
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
+8.47%
1M Performance:
-1.25%
6M Performance:
-68.56%
1Y Performance:
-71.83%
1-Day Range:
$9.22
$9.7499
1-Week Range:
$8.66
$9.75
52-Week Range:
$8.35
$34.07
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EVH
Evolent Health Inc
|
9.48 | 1.11B | 2.35B | -74.42M | 150.93M | -0.94 |
|
VEEV
Veeva Systems Inc
|
233.46 | 37.90B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
74.01 | 12.80B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
64.30 | 12.07B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
95.78 | 8.30B | 1.15B | 96.70M | -161.99M | 1.09 |
|
TEM
Tempus Ai Inc
|
45.50 | 7.84B | 640.44M | -743.28M | -206.93M | -11.29 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-25 | Initiated | Needham | Buy |
| Dec-03-24 | Reiterated | BTIG Research | Buy |
| Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Aug-09-24 | Upgrade | Truist | Hold → Buy |
| Apr-22-24 | Initiated | Citigroup | Buy |
| Mar-01-24 | Initiated | Oppenheimer | Outperform |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Oct-16-23 | Initiated | UBS | Buy |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Nov-01-22 | Initiated | Truist | Hold |
| Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-29-21 | Resumed | JP Morgan | Neutral |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
| Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Oct-05-18 | Resumed | Leerink Partners | Outperform |
| Jun-04-18 | Initiated | Piper Jaffray | Overweight |
| Apr-24-18 | Resumed | JP Morgan | Neutral |
| Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-02-17 | Initiated | Robert W. Baird | Outperform |
| Mar-14-17 | Initiated | Oppenheimer | Outperform |
| Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Oct-28-16 | Resumed | JP Morgan | Overweight |
| Aug-05-16 | Reiterated | FBR Capital | Outperform |
| Jul-26-16 | Initiated | Jefferies | Buy |
| Jul-13-16 | Reiterated | FBR Capital | Outperform |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
| Jan-06-16 | Initiated | Canaccord Genuity | Buy |
| Jun-30-15 | Initiated | Goldman | Buy |
| Jun-30-15 | Initiated | JP Morgan | Overweight |
| Jun-30-15 | Initiated | Leerink Partners | Outperform |
| Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Define Ventures Appoints Carolyn Magill as Venture Partner - Quantisnow
Define Ventures Appoints Carolyn Magill as Venture Partner – Company Announcement - Financial Times
Evolent Health (NYSE:EVH) Given New $12.00 Price Target at JPMorgan Chase & Co. - Defense World
Evolent Health, Inc. (NYSE:EVH) Receives Average Rating of “Buy” from Analysts - Defense World
Evolent health director Brendan Springstubb acquires $139,050 in stock By Investing.com - Investing.com South Africa
Evolent Health director Keck Kim buys $99,497 in stock By Investing.com - Investing.com South Africa
Beyond The Numbers: 18 Analysts Discuss Evolent Health Stock - Benzinga
Evolent health director Peter Grua acquires $99,470 in shares By Investing.com - Investing.com Australia
Evolent Health CEO Seth Blackley purchases $497,577 in stock By Investing.com - Investing.com Canada
Evolent Health president Daniel McCarthy buys $99,470 in stock By Investing.com - Investing.com Canada
Evolent health director Diane Holder buys shares worth $25,517 By Investing.com - Investing.com Australia
Evolent health director Jelinek acquires $273,750 in stock - Investing.com
Evolent Health president Daniel McCarthy buys $99,470 in stock - Investing.com India
Evolent health director Brendan Springstubb acquires $139,050 in stock - Investing.com India
Evolent Health director Glass Russell Monroe acquires $50,058 in stock - Investing.com India
Evolent Health director Keck Kim buys $99,497 in stock - Investing.com India
Evolent Health price target lowered to $12 from $13 at JPMorgan - TipRanks
Evolent health director Diane Holder buys shares worth $25,517 - Investing.com
Evolent Health Executives and Directors Acquire Shares - TradingView
Evolent Health Insider Bought Shares Worth $273,750, According to a Recent SEC Filing - Marketscreener.com
Evolent Health CEO Seth Blackley purchases $497,577 in stock - Investing.com
Evolent Health Insider Bought Shares Worth $497,577, According to a Recent SEC Filing - Marketscreener.com
Evolent Health Executives Increase Holdings Through Recent Stock Purchases - TradingView
Evolent Health director Craig Barbarosh buys $17,620 in stock - Investing.com
Evolent Health director Craig Barbarosh buys $17,620 in stock By Investing.com - Investing.com UK
3 Reasons to Sell EVH and 1 Stock to Buy Instead - The Globe and Mail
Challenges Persist for Evolent Health as Stock PlummetsNews and Statistics - IndexBox, Inc.
Evolent Health, Inc. (NYSE:EVH) Position Raised by Principal Financial Group Inc. - Defense World
Upcoming Events - Financial Content
Evolent Health (NYSE:EVH) Trading 4.9% Higher on Insider Buying Activity - Defense World
Insider Buying: Brendan Springstubb Acquires Shares of Evolent H - GuruFocus.com
Director Makes Bold Move with Major Evolent Health Stock Purchase - TipRanks
Evolent health director Brendan Springstubb acquires $43,750 in stock - Investing.com India
Evolent health director Brendan Springstubb acquires $43,750 in stock By Investing.com - Investing.com UK
Handelsbanken Fonder AB Boosts Stock Holdings in Evolent Health, Inc. (NYSE:EVH) - Defense World
Evolent Health, Inc. to Host Earnings Call - ACCESS Newswire
Evolent Health Inc Class A to Host Earnings Call - ACCESS Newswire
Relative Strength Alert For Evolent Health - Nasdaq
Evolent Health: Health Insurance Headwinds Aren't Helping BusinessRating Downgrade - Seeking Alpha
How To Trade (EVH) - Stock Traders Daily
Evolent Health stock hits 52-week low at $9.44 amid market challenges - Investing.com India
Evolent Health stock hits 52-week low at $9.44 amid market challenges By Investing.com - Investing.com South Africa
Evolent Health's SWOT analysis: stock faces oncology cost headwinds, AI potential By Investing.com - Investing.com South Africa
Evolent Health's SWOT analysis: stock faces oncology cost headwinds, AI potential - Investing.com
Evolent Health outlines 15%-18% growth target for 2025 amid oncology trend challenges - MSN
Evolent Health price target raised to $13 from $12 at Citizens JMP - TipRanks
Evolent Health stock target raised to $13 at Citizens JMP By Investing.com - Investing.com South Africa
Evolent Health stock target raised to $13 at Citizens JMP - Investing.com India
Evolent Health’s (EVH) Buy Rating Reiterated at Needham & Company LLC - Defense World
Evolent Health Inc. Reports Mixed Earnings Results - TipRanks
Evolent Health Reports Growth and Strategic Gains - TipRanks
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.01%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):